Floatz logo

Therapeutic Asset Ratings

395 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Hrs-6208
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.P1/2CC (40)
inm176
Prostate Cancer
Milton S. Hershey Medical CenterP1/2CC (40)
inr102
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., LtdP1/2CC (40)
Lutetium Dgul
Prostate Cancer
Cellbion Co., Ltd.P1/2CC (40)
Lutetium Lu 177 Jh020002
Prostate Cancer
Bivision Pharmaceuticals, Inc.P1/2CC (40)
mdx2001
Prostate Cancer
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (40)
Mrt-2359
Prostate Cancer
Monte Rosa Therapeutics, IncP1/2CC (40)
mt-4561
Prostate Cancer
Tanabe Pharma America, Inc.P1/2CC (40)
Multiple Single Doses Of 225Ac-J591
Prostate Cancer
Weill Medical College of Cornell UniversityP1/2CC (40)
Mva-Pcaq
Prostate Cancer
Barinthus BiotherapeuticsP1/2CC (40)
Pocenbrodib
Prostate Cancer
Pathos AI, Inc.P1/2CC (40)
rc48
Prostate Cancer
Tianjin Medical University Second HospitalP1/2CC (40)
Rezatapopt
Prostate Cancer
PMV Pharmaceuticals, IncP1/2CC (40)
Rifaximin
Prostate Cancer
Mansoura UniversityP1/2CC (40)
SL-28
Prostate Cancer
Second Life TherapeuticsP1/2CC (40)
Solnerstotug
Prostate Cancer
Sensei Biotherapeutics, Inc.P1/2CC (40)
st101
Prostate Cancer
Sapience TherapeuticsP1/2CC (40)
SX682
Prostate Cancer
National Cancer Institute (NCI)P1/2CC (40)
Tazemetostat
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.P1/2CC (40)
tb511
Prostate Cancer
Twinpig Biolab, Inc.P1/2CC (40)
T-Dxd
Prostate Cancer
AstraZenecaP1/2CC (40)
TIPIRACIL
Prostate Cancer
Parabilis Medicines, Inc.P1/2CC (40)
tng348
Prostate Cancer
Tango Therapeutics, Inc.P1/2CC (40)
Trifluridine
Prostate Cancer
Parabilis Medicines, Inc.P1/2CC (40)
Verteporfin
Prostate Cancer
SpectraCure ABP1/2CC (40)
Showing 251 to 275 of 395 assets
PreviousPage 11 of 16Next